22nd Century Group Inc. (NYSE American: XXII) Attends 31st Annual ROTH Conference
22nd Century Group (NYSE American: XXII) is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. The company’s primary mission in tobacco is to reduce the harm caused by smoking. The company’s primary mission in hemp/cannabis is to develop proprietary hemp strains for important new medicines and agricultural crops. For more information, visit the company's website at www.xxiicentury.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access…







